These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33817624)

  • 21. Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.
    Ibrahim R; Ali SA; Kazi AM; Rizvi A; Guterman LB; Bednarczyk RA; Kim E; Park S; Paulos S; Jeyachandran A; Patel D; Gorantla Y; Wong E; Rajam G; Schiffer J; Omer SB
    Vaccine; 2018 Nov; 36(46):7048-7053. PubMed ID: 30297122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
    Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate: A cross-sectional serological study.
    Cardona RSB; Weckx LY; de Moraes-Pinto MI; Ramos BCF; Dos Santos ARA; Spina FG; de Araújo BC; Clemens R; Clemens SAC
    Vaccine; 2023 Sep; 41(39):5769-5774. PubMed ID: 37573201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm-Born Infants.
    Maertens K; Orije MRP; Herzog SA; Mahieu LM; Hens N; Van Damme P; Leuridan E
    Clin Infect Dis; 2022 Jan; 74(2):189-198. PubMed ID: 33971009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP∼T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy.
    Maertens K; Orije MRP; Huoi C; Boisnard F; Lyabis O
    Vaccine; 2023 Jan; 41(3):795-804. PubMed ID: 36528443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Lima L; Molina MDGF; Pereira BS; Nadaf MLA; Nadaf MIV; Takano OA; Carneiro-Sampaio M; Palmeira P
    Vaccine; 2019 May; 37(19):2569-2579. PubMed ID: 30955978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy.
    Hoang HT; Leuridan E; Maertens K; Nguyen TD; Hens N; Vu NH; Caboré RN; Duong HT; Huygen K; Van Damme P; Dang AD
    Vaccine; 2016 Jan; 34(1):151-9. PubMed ID: 26529073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age.
    Maertens K; Caboré RN; Huygen K; Vermeiren S; Hens N; Van Damme P; Leuridan E
    Vaccine; 2016 Jun; 34(31):3613-9. PubMed ID: 27142328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence.
    Chaithongwongwatthana S; Wijagkanalan W; Wanlapakorn N; Fortuna L; Yuwaree V; Kerdsomboon C; Poredi IK; Mansouri S; Pham HT; Poovorawan Y
    Int J Infect Dis; 2024 Jul; 144():107047. PubMed ID: 38609035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Milk Antibody Levels in Tdap-Vaccinated Women After Preterm Delivery.
    Orije MRP; Larivière Y; Herzog SA; Mahieu LM; Van Damme P; Leuridan E; Maertens K
    Clin Infect Dis; 2021 Sep; 73(6):e1305-e1313. PubMed ID: 33768227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
    Abu-Raya B; Maertens K; Munoz FM; Zimmermann P; Curtis N; Halperin SA; Rots N; Barug D; Holder B; Rice TF; Kampmann B; Leuridan E; Sadarangani M
    Vaccine; 2021 Oct; 39(44):6545-6552. PubMed ID: 34598822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers.
    McAlister SM; van den Biggelaar AHJ; Woodman TL; Hutton H; Thornton RB; Richmond PC
    Vaccine; 2021 Mar; 39(11):1642-1651. PubMed ID: 33589299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
    Wanlapakorn N; Maertens K; Chaithongwongwatthana S; Srimuan D; Suratannon N; Vongpunsawad S; Tran TMP; Hens N; Van Damme P; Locht C; Poovorawan Y; Leuridan E
    Vaccine; 2018 Mar; 36(11):1453-1459. PubMed ID: 29426663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
    Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
    Front Immunol; 2019; 10():2423. PubMed ID: 31681310
    [No Abstract]   [Full Text] [Related]  

  • 36. Maternal and neonatal antibody levels on pertussis vaccination in pregnant women on immune-modulating therapy for rheumatic disease.
    Ghalandari N; Immink MM; Röder E; Bruijning-Verhagen PCJ; Smeele H; Crijns H; van der Maas NAT; Bekker MN; Sanders EAM; Dolhain RJEM
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37640516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
    Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants.
    Immink MM; Bekker MN; de Melker HE; Rots NY; Sanders EAM; van der Maas NAT
    BMC Infect Dis; 2021 Sep; 21(1):897. PubMed ID: 34479491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
    Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
    Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.